Abbonarsi

Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis - 09/01/21

Doi : 10.1016/j.jaci.2020.06.037 
Stephen Shih-Teng Kao, MBBS a, Ahmed Bassiouni, PhD a, Mahnaz Ramezanpour, PhD a, John Finnie, PhD b, Nusha Chegeni, BSc b, c, Alex D. Colella, PhD b, c, Timothy K. Chataway, PhD b, c, Peter-John Wormald, MD a, Sarah Vreugde, PhD a, Alkis James Psaltis, PhD a,
a Department of Surgery-Otolaryngology Head and Neck Surgery, The University of Adelaide, Woodville South, Australia 
b Discipline of Anatomy and Pathology, Adelaide Medical School, The University of Adelaide and South Australia Pathology, Adelaide, Australia 
c Flinders Proteomic Facility, Department of Human Physiology, Flinders University, Bedford Park, Australia 

Corresponding author: Alkis Psaltis, MBBS, PhD, FRACS, Department of Otolaryngology, Head and Neck Surgery, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, South Australia 5011, Australia.Department of OtolaryngologyHead and Neck SurgeryThe Queen Elizabeth Hospital28 Woodville RoadWoodville SouthSouth Australia5011Australia

Abstract

Background

Chronic rhinosinusitis (CRS) has a complex and multifactorial pathogenesis with a heterogeneous inflammatory profile. Proteomic analysis of nasal mucus may enable further understanding of protein abundances and biologic processes present in CRS and its endotypes compared with in healthy patients.

Objective

Our aim was to determine differences in the nasal mucus proteome of healthy patients and patients with CRS.

Methods

Nasal mucus was obtained from healthy patients, patients with CRS without nasal polyps (CRSsNP), and patients with CRS with nasal polyps (CRSwNP) before surgery. Gel electrophoresis was performed to fractionate the complex protein extracts before mass spectrometry analysis. Gene set enrichment analysis was performed on differentially expressed proteins.

Results

A total of 33 patients were included in this study (12 healthy, 10 with CRSsNP, and 11 with CRSwNP). In all, 1142 proteins were identified in mucus samples from healthy patients, 761 in mucus samples from patients with CRSsNP, and 998 in mucus samples from patients with CRSwNP. Dysfunction in immunologic pathways, reduced cellular signaling, and increased cellular metabolism with associated tissue remodeling pathways were present in patients with CRS compared with in healthy patients.

Conclusion

Significant downregulation of mucosal immunity and antioxidant pathways with increased tissue modeling processes may account for the clinical manifestations of CRS. Ultimately, the differing proteome and biologic processes provide further insight into CRS pathogenesis and its endotypes.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : Nasal mucus, proteomics, chronic rhinosinusitis, nasal polyps, endotypes, proteins

Abbreviations used : CRS, CRSsNP, CRSwNP, emPAI, GO, GSEA, MS, ROS


Mappa


 This project was supported by the Adelaide University Research Training Program Scholarship, Bertha Sudholz Research Scholarship, and Garnett Passe Rodney Williams Memorial Foundation Scholarship.
 Disclosure of potential conflict of interest: P.-J. Wormald receives royalties from Medtronic, Integra, and Scopis, and he is a consultant for NeulMed. A. J. Psaltis is a consultant for Tissium, Medtronic, and ENT Technologies. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 1

P. 168-178 - Gennaio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease
  • Alison J. Dicker, Jeffrey T.J. Huang, Mike Lonergan, Holly R. Keir, Christopher J. Fong, Brandon Tan, Andrew J. Cassidy, Simon Finch, Hana Mullerova, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers
| Articolo seguente Articolo seguente
  • A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps
  • Tim Delemarre, Gabriele Holtappels, Natalie De Ruyck, Nan Zhang, Hans Nauwynck, Claus Bachert, Elien Gevaert

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.